Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-25-041315
Filing Date
2025-03-18
Accepted
2025-03-18 16:48:59
Documents
6
Effectiveness Date
2025-03-18

Document Format Files

Seq Description Document Type Size
1 S-8 pyxs_s-8_evergreen_share.htm S-8 135070
2 EX-5.1 pyxs-ex5_1.htm EX-5.1 22800
3 EX-23.2 pyxs-ex23_2.htm EX-23.2 3756
4 EX-FILING FEES pyxs-exfiling_fees.htm EX-FILING FEES 43298
5 GRAPHIC img83719486_0.jpg GRAPHIC 13077
6 GRAPHIC img83719486_1.jpg GRAPHIC 13077
  Complete submission text file 0000950170-25-041315.txt   242244
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

EIN.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285889 | Film No.: 25749160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)